Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent Xeloda and Radiotherapy for Bone Metastases

NCT00192777 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT00192777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00192777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent Xeloda and Radiotherapy for Bone Metastases
Lead sponsor
Rambam Health Care Campus
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2004
Completion date
Not reported
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, solid tumors